Q3 2017 13F Holders as of 9/30/2017
-
Type / Class
-
Equity / Common Stock, $0.01 par value per share
-
Shares outstanding
-
50.5M
-
Number of holders
-
331
-
Total 13F shares, excl. options
-
45.9M
-
Shares change
-
-145K
-
Total reported value, excl. options
-
$4.96B
-
Value change
-
-$9.17M
-
Put/Call ratio
-
2.7
-
Number of buys
-
178
-
Number of sells
-
-130
-
Price
-
$108.02
Significant Holders of CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share (CRL) as of Q3 2017
361 filings reported holding CRL - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share as of Q3 2017.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share (CRL) has 331 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 45.9M shares
of 50.5M outstanding shares and own 90.89% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (4.99M shares), BlackRock Inc. (4M shares), FMR LLC (2.96M shares), ARIEL INVESTMENTS, LLC (1.68M shares), AQR CAPITAL MANAGEMENT LLC (1.51M shares), RENAISSANCE TECHNOLOGIES LLC (1.34M shares), STATE STREET CORP (1.25M shares), GOLDMAN SACHS GROUP INC (1.02M shares), MACKENZIE FINANCIAL CORP (929K shares), and MORGAN STANLEY (900K shares).
This table shows the top 331 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.